Medicinal Chemistry Consultancy

The RGD integrins may be another druggable target (in addition to ACE-2) that prevents cell entry by COVID-19

This could initiate further research into finding effective treatments for cancer

This work could significantly further our understanding of integrin signalling. It will be very interesting to observe if this is shown for the other integrin proteins.